1 st European Conference on Mesenchymal Stem Cells TOULOUSE, November 18-20, 2010
|
|
|
- Teresa Crawford
- 5 years ago
- Views:
Transcription
1 1 st European Conference on Mesenchymal Stem Cells TOULOUSE, November 18-20, 2010 Sciientiiffiic Commiittee Louis Casteilla, Fancesco Dazzi, Willem Fibbe, Christian Jorgensen, Mauro Krampera, Katarina LeBlanc, Hubert Schrezenmeier, Luc Sensebé, Karin Tarte
2 In collaboration with:
3 Day 1, Thursday, November 18 th :30 Registration 9:00 Welcome to the 1 st European MSC by the Scientific Committee Session A Generrall Biiollogy off MSCs 9:20-10:00 Keynote speaker Introductory lecture Mesenchymal Niche Cells in Haemopoiesis Scadden D (USA) 10:00-10:30 Functional Complexity of MSC Populations Phinney D (USA) 10:30-11:00 Native and Cultured MSC Charbord P (France) 11:00-11:30 Coffee break and Poster 11:30-12:00 Origin of MSC during Embryogenesis Era T (Japan) 12:00-12:30 Vessels as a Reservoir of MSC Péault B (USA) 12:30-13:15 Luncheon and Poster 13:15-14:00 CaridianBCT Demonstration Session B MSC and IImmunollogy 14:15-14:35 MSC: Immune Tolerance and Tissue Repair Dazzi F (UK) 14:35-14:55 Licensing of MSC Krampera M (Italy) 14:55-15:15 Mesenchymal Stromal Cells: Hierarchical Relations and Imunne properties Fibbe W (Netherlands) 15:15-15:35 MSC and T Cell Differentiation Jorgensen C (France) 15:35-15:55 MSC for autoimmune diseases: from mice to men Uccelli A (Italy) 16:00-16:30 Coffee break and Poster 16:35-17:50 Selected Abstracts 16:35-16:50 Does Activin A Determine Mesenchymal Stem Cell Multipotency? F. Djouad (Poster 9) 16:50-17:05 Mesenchymal stromal cells derived from CD271+ bone marrow mononuclear cells improve the lymphohematopoietic engraftment of CD133+ hematopoietic stem cells. Z. Kuci (Poster 13)
4 17:05-17:20 Human Mesenchymal Stem Cells Trigger the Instant Blood Mediated Inflammatory Reaction in ABO-compatible Human Blood. G. Moll (Poster 18) 17:20-17:35 Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? L. Lonnies (Poster 27) 17:35-17:50 The source of human mesenchymal stromal (MSC) cells influences their TLR profile as well as their functional properties. G. Raicevic (Poster 32) Day 2, Friday, November 19 th 2010 Session C MSC iin rregenerrattiive mediiciine 1 9:00-9:30 Mechanisms underlying limb regeneration in an adult vertebrate Keynote speaker: Brockes JP (UK) 9:30-9:50 MSC and Bone Repair Dominici M (Italy) 9:50-10:10 Biomaterials/Cells De Boer J (Netherlands) 10:10-10:30 MSC & Cartilage Repair Noel D (France) 10:30-10:50 3D Culture Genever P (UK) 10:50-11:20 Coffee break and Poster MSC iin rregenerrattiive mediiciine 2 11:20-11:40 ADSC & Cardiovascular Repair Planat-Benard V (France) 11:40-12:00 MSC and Kidney Disorders Zander A (Germany) 12:05-13:05 Selected Abstracts 12:05-12:20 Efficiency of human bone marrow-derived mesenchymal stem cells to promote epidermal development in an in vitro reconstituted skin. L. Micallef (Poster 17) 12:20-12:35 Alternative sources of mesenchymal stem cells to cure experimental acute kidney injury. M. Morigi (Poster 42) 12h35-12h50 Mesenchymal Stem Cells Promote Long Term Survival Of Intracerebral Transplant. P. Naveilhan (Poster 43) 12h50-13h05 Large-scale production of human mesenchymal stem cells in microcarrier-based suspension bioreactors with defined serum-free medium for their use in clinical applications. S. Jung (Poster 50) 13:10-14:00 Luncheon and Poster Session D Regullattorry Affffaiirrs and Saffetty 14:00-14:20 Clinical Uses of MSCs European Regulations Migliaccio G (Italy) 14:20-14:40 Controls of Cultured MSC Sensebé L (France)
5 14:40-15:00 MSC Production in Closed Systems Schrezenmeier H (Germany) 15:00-16:05 From Research to Products & Trials: Where do we stand & what do we need? Round Table 16:05-16:30 Coffee break and Poster Session E Ongoiing & ffutturre clliiniicall ttrriialls 16:30-16:45 Clinical Trials History and Overview Keynote speaker: Le Blanc K (Sweden) 16:45-17:00 ADSC/MSC in Cardiovascular Disease Bourin P (France) 17:00-17:15 Therapy and Crohn Disease Garcia-Olmo D (Spain) 17:15-17:30 Cell Therapy for CNS Siddarthan Chandran (UK) 17:30-17:45 MSC for Bone Repair Petite H (France) 17:45-18:00 Lessons from Cartilage Repair Brittberg M (Sweden) Galla Diinnerr,, Ciitté de ll Espace,, Toullouse Day 3, Saturday, November 20 th 2010 Session F MSC iin norrmall & patthollogiicall miicrroenviirronmentt 9:00-9:30 Organization of Immunological Memory by Bone Marrow Stroma Chang HD (Germany) 9:30-9:50 MSC in Lymphoid Organs Cupedo T (Netherlands) 9:50-10:10 MSC in lymphoid Malignancies Tarte K (France) 10:10-10:30 MSCs within Solid Tumor Microenvironment Östman A (Sweden) 10:35-11:00 Coffee break and Poster 11:00-11:45 Best Selected Abstracts 11:00-11:15 Human Bone Marrow Pericytic Cells Are More Immature Than Mesenchymal Stem Cells Cultured In Standard Conditions. A. Bouacida (Poster 7) 11:15-11:30 Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. M. W. Maijenburg (Poster 15) 11:30-11:45 Notch-3 and notch-4 signaling rescues from apoptosis human b-lineage acute lymphoblastic leukemia cells in
6 contact with human bone marrow-derived mesenchymal stromal cells. AH Nwabo Kamdje (Poster 20) 11:45 European MSC Prize 12:00 Concluding Remarks 13:30 General Meeting of European Consortium AdipoA Reborne
Stephen Strom (Cell Transplantation and Regenerative Medicine, KI) Stem Cell Therapy of Liver Disease
Final Programme Tuesday 13 th October Location: HERM Seminar Room, NOVUM, 4 th Floor (entrance through HERM) 9.15-9.20 Welcome and Introduction to the Sessions Chair: Hong Qian (HERM, KI) 9.20-10.15 Hong
At the conclusion of this lesson you should be able to:
Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate
Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)
STEM CELLS (p 2-8) Overview The body is made up of about 200 different kinds of specialised cells, such as muscle cells, nerve cells, fat cells and skin cells. Cells with the capacity to give rise to the
Cultrex Rat Mesenchymal Stem Cell Growth and Differentiation Products
ITM-2011/06/07 Cultrex Rat Mesenchymal Stem Cell Growth and Differentiation Products Background: Mesenc ymal Stem Cells (MSC), also known as marrow stromal cells, are a self - renewing population of multipotent
NPTEL Biotechnology Tissue Engineering. Stem cells
Stem cells S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs and IISc
leading the way in research & development
leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and
Andrew Finnerty General Manager - CCMI
Andrew Finnerty General Manager - CCMI Manufacturing Human Mesenchymal Stem Cells for Clinical Trials Quality Considerations Biopharma and Pharma RQA Regional Forum Bioclin Laboratories, Athlone 13 May
Mesenchymal Stromal/Stem Cells
Mesenchymal Stromal/Stem Cells Peiman Hematti, M.D. Department of Medicine Financial Disclosure: Consulting Fees from Celgene Cellular Therapeutics in 2011 & 2012 1 Caplan used the term Mesenchymal Stem
Mesenchymal Stromal Cells Large-scale Culture
Mesenchymal Stromal Cells Large-scale Culture Adrian Gee Center for Cell & Gene Therapy Baylor College of Medicine Houston, Texas Hanley et al: Efficient manufacturing of therapeutic mesenchymal stromal
Stem Cel s Key Words:
Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,
The Cell and Gene Therapy Catapult UK clinical trials database
The Cell and Gene Therapy Catapult UK clinical trials database The UK clinical trials database covers cell and gene therapy clinical trial activities that the Cell and Gene Therapy Catapult (CGT Catapult)
ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development
ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the
Stem Cells: Introduction and Prospects in Regenerative Medicine.
Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,
Stem Cell Research From Bench to Bedside
Stem Cell Research From Bench to Bedside Stem Cell Dialogues Jan A. Nolta, Ph.D. Professor, Internal Medicine Director, UC Davis Institute for Regenerative Cures October 26, 2010 Stem Cells at UC Davis
Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST
Future of Stem Cell Engineering i Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Keywords of Stem Cell Engineering g Embryo and Fetus (Foetus) Adult stem cells and embryonic stem cells
About ATCC. Established partner to global researchers and scientists
Discovering ATCC Primary Immunology Cells - Model Systems to Study the Immune and Cardiovascular Systems James Clinton, Ph.D. Scientist, ATCC July 14, 2016 About ATCC Founded in 1925, ATCC is a non-profit
Mid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1
Mid-term review Recitation5 03/31/2014 Stem Cell Biology and Function W4193 1 What to expect in the midterm2 It will be all so far but mainly whatever was NOT covered by the previous mid-term- not a huge
Cases of Academic Misconduct. Core Components
Cases of Academic Misconduct May 2015 Examination Session Core Components Extended Essay / Biology Infringement: Plagiarism Pages 1-6 show no evidence of plagiarism. Comments A significant portion of the
Regenerative Medicine and Stem Cell Therapies
Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating
Fundamental properties of Stem Cells
Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell
NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:
NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s
Cell-based therapies in tissue engineering and regenerative medicine (TE/RM)
Cell-based therapies in tissue engineering and regenerative medicine (TE/RM) Pamela Gehron Robey, Ph.D. Craniofacial and Skeletal Diseases Branch National Institutes of Dental and Craniofacial Research
ANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134)
ANNOUNCEMENTS HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Lectures 6 8 Outline Stem Cell Division - symmetric - asymmetric Stem cell lineage potential - pluripotent
The Cell and Gene Therapy Catapult UK clinical trials database
The Cell and Gene Therapy Catapult UK clinical trials database The UK clinical trials database covers cell and gene therapy clinical trial activities that the Cell and Gene Therapy Catapult (CGT Catapult)
Geneva. Call for Abstracts, Registration and Accommodation Brochure. 9th International Conference on New Trends in Immunosuppression & Immunotherapy
Geneva 2010Immuno 9th International Conference on New Trends in Immunosuppression & Immunotherapy February 4-6, 2010, Geneva, Switzerland Geneva 2010 Immuno Deadline for Abstract Submission: October 20,
Regulation of advanced blood cell therapies
Regulation of advanced blood cell therapies www.pei.de Clinical trials using cell-based products Substantially manipulated cells and cells for non-homologous use Quality, safety and non-clinical aspects
ISSCR 2017 Abstract Submission Guide
ISSCR 2017 Abstract Submission Guide The International Society for Stem Cell Research (ISSCR) invites the submission of abstracts that report new research developments across the breadth of stem cell biology,
Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products. Rod Monroy, Ph.D. Director, Prochymal
Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products Rod Monroy, Ph.D. Director, Prochymal Safe harbor This presentation contains, and answers given to questions that
4 th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods, Perspectives" April 2007
4 th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods, Perspectives" 16-19 April 2007 at the and Institute of Transfusion Medicine (Building of
Erectile and voiding dysfunction: will stem cells solve it all?
Erectile and voiding dysfunction: will stem cells solve it all? Maarten Albersen MD PhD Dept. of Development and Regeneration Leuven University, Belgium Disclosures No conflicts of interest. ED stem cell
Introduction to Cell- Biomaterial Engineering!
Introduction to Cell- Biomaterial Engineering! Module 3, Lecture 1! 20.109 Spring 2010! Topics for Lecture 1!! Introduction to tissue engineerin! motivation"! basic principles + examples"! Introduction
Des cellules-souches dans le poumon : pourquoi faire?
Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland
Mesenchymal Stem Cell Characterization. Peiman Hematti, M.D. Department of Medicine
Mesenchymal Stem Cell Characterization Peiman Hematti, M.D. Department of Medicine Terminology has evolved over the years: Colony forming units-fibroblasts (CFU-E) Fibroblast colony forming cells (FCFC)
SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]
![SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]](/thumbs/93/114360204.jpg "SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]")
SCM Lifescience [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea 22332 [Website] http://www.scmlifescience.com COMPANY PROFILE [Industry] SCM Lifescience is a research-based biopharmaceutical company
8 th Regenerative Medicine and Stem Cells
8 th Regenerative Medicine and Stem Cells Theme: Light the Hope of Incurable Diseases March 19 21, 2 15 Busan, Republic of Korea Welcome Message Dear Friends and Colleagues, On behalf of the Organizing
The Role of Adult Stem Cells in Personalized and Regenerative Medicine
The Role of Adult Stem Cells in Personalized and Regenerative Medicine Christopher J. Neill, Director of Corporate Operations American CryoStem Corporation Objective To illustrate the potential benefits
BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics
BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics I. B cell leukemia and lymphomas Immunophenotyping as part of the diagnostic work- up of hematologic malignancies offers a rapid and effective
Regenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016
Regenerative Medicine Halland Chen, MD Speaker Disclosures I disclose that I am not a consultant or have any financial interests. 2 What is regenerative medicine? Regeneration of human cells, tissues,
The Science of Stem Cell Therapy
The Science of Stem Cell Therapy AVM Biotechnology City Centre Building 1420 Fifth Avenue, Suite 2650 Seattle, WA 98101 206-906-9922 www.avmbiotech.com Copyright 2008 AVM Biotechnology, LLC speaker disclosure
EMA s role & responsibility for the development of modern/advanced therapies
EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory
Understanding brain diseases from stem cells to clinical trials
Understanding brain diseases from stem cells to clinical trials Alan Mackay Sim Griffith Institute for Drug Discovery Griffith University Brisbane, QLD Making ES cells Fertilise an egg Put in a dish Embryonic
The NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
Clinical Applications of Mesenchymal Stem Cell Therapy
Clinical Applications of Mesenchymal Stem Cell Therapy Dr R R Sharma MD Professor Department of Transfusion Medicine Postgraduate Institute of Medical Education and Research, Chandigarh, India What are
PRIME-XV Cell Therapy Products by
PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide
Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics
Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire
Japan : Victoria Business Forum
Japan : Victoria Business Forum Silviu Itescu Chief Executive 25 August 2015 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation, including any comments made during or following the
PRIME-XV Cell Therapy Products by
PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide
Welcome to the. 1 st workshop: Drawing lessons from stem cells and animal models outside the radiation field
Welcome to the 1 st workshop: Drawing lessons from stem cells and animal models outside the radiation field Context of the workshop Long-term animal studies have played fundamental roles for studies on
Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013
Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells
Supplementary Figures
Supplementary Figures Supplementary Figure 1: Phenotypically defined hematopoietic stem and progenitor cell populations show distinct mitochondrial activity and mass. (A) Isolation by FACS of commonly
Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation
Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Learning Goals I can explain the concept of cell differentiation and cell specialization. I can explain how the cell structure relates
Introduction to Nanotechnology
Introduction to Nanotechnology Textbook: Nanophysics and Nanotechnology by: Edward L. Wolf Instructor: H. Hosseinkhani E-mail: hosseinkhani@yahoo.com Classroom: A209 Time: Thursday; 13:40-16:30 PM Office
Stem Cell Uses and FDA Regulation
Stem cells have been called everything from cure-alls to miracle treatments. But don t believe the hype. Some unscrupulous providers offer stem cell products that are both unapproved and unproven. So beware
Stem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan
Stem Cells & Neurological Disorders Said Ismail Faculty of Medicine University of Jordan Outline: - Introduction - Types & Potency of Stem Cells - Embryonic Stem Cells - Adult Stem Cells - ipscs -Tissue
1 st Saudi Hematology Research Day 04 March 2016 (Friday), Riyadh Marriot Hotel, 6:00 PM 9:00 PM
1 st Saudi Hematology Research Day TIME SESSION TITLE PRESENTER 6:00-6:25 PM Registration 6:25-6:30 PM Opening Remarks Almohareb / Alfraih 6:30-6:40 PM Research in Saudi Arabia Aljurf 6:40-7:00 PM Abstracts
Dr. Nazareth Gengozian (Photo courtesy of Oak Ridge Associated Universities)
At age 77, Dr. Gengozian retired. He expressed his decision this way, I had been very fortunate to have had a professional career which I loved very much: The freedom to pursue basic research with only
All contents herein are the sole property of MEDIPOST Co., Ltd. Any reproduction or distribution of this document without the written consent of
All contents herein are the sole property of MEDIPOST Co., Ltd. Any reproduction or distribution of this document without the written consent of MEDIPOST Co., Ltd is prohibited. Copyright c 2004-2011 MEDIPOST.
From basic research to clinical practice, this multidisciplinary event provides an opportunity to share and compare research progress and clinical experiences to establish reliable stem cell and other
Research Xchange Forum 2018
Research Xchange Forum 2018 Insights Translation Solutions Trends and Challenges in Regenerative Medicine & Cell Therapy March 20 21, 2018 Sartorius Goettingen, Germany What to expect Learn about the latest
Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018
Adult Stem Cells for Chronic Pain Dr. John Hughes, DO January 24 th, 2018 Dr. John Hughes, DO Doctor of Osteopathy From Georgia Arizona College of Osteopathic Medicine - 2007 Aspen Integrative Medicine
Characterization of Human MSCs Cultured in MesenCult -XF
TECHNICAL BULLETIN Characterization of Human MSCs Introduction Mesenchymal stem cells (MSCs), which have been more recently termed multipotent mesenchymal stromal cells, are plasticadherent, fi broblast-like
Towards a stem cell based therapy for Parkinson s Disease
Stem cell based therapies for Parkinson s Disease Towards a stem cell based therapy for Parkinson s Disease MALIN PARMAR NYSCF Robertson Investigator Lund University, Sweden INTR, Port Douglas, Sept 13-16,
Supplemental Information
Supplemental Information DLA-matched bone marrow transplantation reverses the immunodeficiency of SCID dogs. Bone marrow transplantation studies were initiated with the goal of reversing the immunodeficiency
Education Critical to Stem Cell Therapy Pipeline
June 2016 Education Critical to Stem Cell Therapy Pipeline Don L. Gibbons Senior Science and Education Communication Officer ABOUT California Institute for Regenerative Medicine (CIRM) CIRM is California
Stem Cells in Life and Disease: Immortality Inside You
Stem Cells in Life and Disease: Immortality Inside You Blair Benham-Pyle Tyler Burns Joe Ouadah Splash! Fall 2011 What do you think a stem cell is? (discuss with people around you) A stem cell is a cell
Stem Cell Research 101
Stem Cell Research : A promising type of bioscience research The Stem Cell debate and the impact of the induced pluripotent stem cell procedure Why Is Vocabulary Important? Key terms frame the debate Mature
Stem cells and tissue engineering
Stem cells and tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative
The niche/microenvironment shapes the fate of researchers and stem cells
The niche/microenvironment shapes the fate of researchers and stem cells Beate Heissig, MD Division of Stem Cell Dynamics Center of Stem Cell Biology and Regenerative Medicine The Institute of Medical
THE THERAPEUTIC REALITIES OF STEM CELLS
Ferghana Partners Group is a Life Sciences investment banking house with offices in London and New York. We specialise in creating and executing effective strategic transactions for pharmaceutical, chemical,
Sharing Data: Recovering Registry Addict
Sharing Data: Observations From a Recovering Registry Addict Christopher Bredeson, MD, MSc., FRCPC Director, Hematologic Malignancies Professor of Medicine Medical College of Wisconsin DBV06_1.ppt TODAY
STEM CELL RESEARCH PRIMER
STEM CELL RESEARCH PRIMER WHAT YOU NEED TO KNOW ABOUT STEM CELLS AND STEM CELL RESEARCH What Stem Cells Are And Why They Are Important Stem cells are the body s very own internal repair system. They are
Company Presentation September 2016
Company Presentation September 2016 Forward looking Statement This presentation concerning Pluristem Therapeutics may include forward-looking statements which represent Pluristem Therapeutics' expectations
Results and Discussion
Growth Kinetics of Human Mesenchymal Stem Cells in a 3L Single-Use, Stirred Tank Bioreactor EMD Millipore Corporation 80 Ashby Rd, Bedford, MA, 01730 www.millipore.com Human mesenchymal stem cells hold
A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of
A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of Auckland Overview What is a stem cell? Discovery - our research
Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL
Outcomes in Mesenchymal Stem Cell Manufacturing Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Background HCTL established in 1992 to support BMT programs of Mayo
Jefferies Healthcare Conference 2016
Jefferies Healthcare Conference 2016 Forward looking Statement This presentation concerning Pluristem Therapeutics may include forward-looking statements which represent Pluristem Therapeutics' expectations
Stem Cells, The Current State of Researches on this Problem and the Main Directions of their Development. From Theory to Clinical Practice
Cronicon OPEN ACCESS EC DENTAL SCIENCE Thematic Article Stem Cells, The Current State of Researches on this Problem and the Main Directions of their Development. From Theory to Andrey Orlov 1 *, A S Grigiryan
Expanding Adipose-Derived Mesenchymal Stem / Stromal Cells In Vitro for Stem Cell Therapies
Expanding Adipose-Derived Mesenchymal Stem / Stromal Cells In Vitro for Stem Cell Therapies Christian Caprara, PhD Swiss Stem Cell Foundation icast 216 Zürich, 31.5.216 Adipose-derived mesenchymal stem
Available through Online
ISSN: 0975-766X CODEN: IJPTFI Available through Online Review Article www.ijptonline.com STEM CELLS-MODERN APPROACH IN MEDICINE Kameshwar Sharma YVR* 1, Prasidhi Tyagi 2 and Samarth Kulshrestha 3 * 1 Department
Induced Stem Cells in Research and Therapy of Neuropsychiatric Disorders
Berlin-Brandenburg Center for Regenerative Therapies Induced Stem Cells in Research and Therapy of Neuropsychiatric Disorders Josef Priller Department of Neuropsychiatry Laboratory of Molecular Psychiatry
Promises and Challenges
Vladimir Mironov & Richard Visconti Regenerative Medicine: Promises and Challenges What is Regenerative Medicine? Regeneration is a well known biological term and phenomenon. According to the popular Webster
Assuring Multipotency of human Mesenchymal Stem Cells (hmsc)
Assuring Multipotency of human Mesenchymal Stem Cells (hmsc) Introduction Over the past decade, stem cell research has provided new avenues for deeper investigation into tissue repair and aging processes,
Stem Cells, Regenerative Medicine and cgmp (GTP)
Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate
Cell and Gene Therapy Catapult clinical trials database
Cell and Gene Therapy Catapult clinical trials database Executive summary The number of cell and gene therapy clinical trials in the UK continues to increase with 85 ongoing trials at present, representing
detection limit of cytomorphological techniques detection limit of immunophenotyping and PCR techniques cure follow-up in years
relative frequency of leukemic cells 1 10-1 10-2 10-3 10-4 10-5 10-6 10-7 0 Detection of minimal residual disease (MRD) detection limit of cytomorphological techniques detection limit of immunophenotyping
THE GLOBAL MARKET FOR STEM CELLS
THE GLOBAL MARKET FOR STEM CELLS BIO035F May 2016 Paul Evers Project Analyst ISBN: 1-62296-292-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the USA),
Presenter: Teresa Holm
Slides are from Level 3 Biology Course Content Day, 7 th November 2012 Presenter: Teresa Holm Teachers are free to use these for teaching purposes with appropriate acknowledgement Human Stem cells Dr Teresa
ANAT 2341 Embryology Lecture 18 Stem Cells
ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera
Gene therapy. Findings by Alert
Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed
Clinical Applications of Mesenchymal Stromal Cells
Clinical Applications of Mesenchymal Stromal Cells John Girdlestone PhD Head of Laboratory Cellular and Molecular Therapies NHSBT Oxford Cellular and Molecular Therapies 7 HTA-licensed Cell Therapy Laboratories
INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE
INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR > SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders
BME 177. Engineering stem cells. Gayatri Pal Lecturer Biomolecular Engineering
BME 177 Engineering stem cells Gayatri Pal Lecturer Biomolecular Engineering Introduction Graduated from MCD Biology (Yeast Cell Cycle) -CIRM classes (Introduction to stem cell biology) Post-doc training
Team Training. Jan Nolta, Ph.D., Director UC Davis Stem Cell Program and Institute for Regenerative Cures. Editor in Chief, Stem Cells
Team Training Jan Nolta, Ph.D., Director UC Davis Stem Cell Program and Institute for Regenerative Cures Editor in Chief, Stem Cells Goal: To improve therapies for our patients through translational research
Leading the world in the development of adult stem cell therapies. June 2014
Leading the world in the development of adult stem cell therapies June 2014 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation, including any comments made during or following the presentation,
Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division
Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division stem cell stem cell skin muscle nerve Properties of STEM cells Plasticity
WHAT TO KNOW BEFORE GETTING STEM CELLS. Dr. John Hughes, DO Aspen Integrative Medicine June 15th, 2017
WHAT TO KNOW BEFORE GETTING STEM CELLS Dr. John Hughes, DO Aspen Integrative Medicine June 15th, 2017 Disclaimer: I have no material interest or investment in any stem cell companies or products. I. Introduction
CELL THERAPY FOR THE TREATMENT OF DAMAGED MYOCARDIUM
CELL THERAPY FOR THE TREATMENT OF DAMAGED MYOCARDIUM Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
Special Issue. Mesoblast Limited
Overview is an Australian biotechnology company committed to the commercialization of novel treatments for orthopedic conditions by using its unique adult stem cell technology for the regeneration and
Adipose Stem Cells as a Feeder Layer Reduce Apoptosis and p53 Gene Expression of Human Expanded Hematopoietic Stem Cells Derived from Cord Blood
Adipose Stem Cells as a Feeder Layer Reduce Apoptosis and p53 Gene Expression of Human Expanded Hematopoietic Stem Cells Derived from Cord Blood Tahereh Foroutan 1 *, Aysan Farhadi 1, Bahram- Mohammad
Guide to Clonetics and Poietics Cell Types
Guide to Clonetics and Poietics Cell Types Clonetics and Poietics Cell Types - Sorted By Tissue Source Cryopreserved Human Cells Adipose Subcutaneous Preadipocytes PT-5001 PGM -2 PT-8002 Visceral Preadipocytes